Literature DB >> 13249617

Fat absorption studies in the diagnosis and treatment of pancreatic fibrosis.

C A ROSS.   

Abstract

Entities:  

Keywords:  FATS/metabolism; PANCREAS/diseases; SPRUE/differential diagnosis

Mesh：

Substances：

Year:  1955        PMID： 13249617      PMCID： PMC2011779          DOI： 10.1136/adc.30.152.316

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  2 in total

1.  Coeliac disease; gastrointestinal studies and the effect of dietary wheat flour.

Authors:  C M ANDERSON; J M FRENCH; H G SAMMONS; A C FRAZER; J W GERRARD; J M SMELLIE
Journal:  Lancet       Date:  1952-04-26       Impact factor: 79.321

2.  Postprandial lipemic response in infants and children.

Authors:  W R ELGHAMMER; J M REICHERT; H F PHILIPSBORN
Journal:  Pediatrics       Date:  1950-04       Impact factor: 7.124
  2 in total
  11 in total

1.  Non-pancreatic lipase in children with pancreatic fibrosis.

Authors:  C A ROSS; H G SAMMONS
Journal:  Arch Dis Child       Date:  1955-10       Impact factor: 3.791

2.  Metabolic studies in a case of fibrocystic disease of the pancreas with reference to treatment and to the incidence of bone disease.

Authors:  M A PARFIT; J R NASSIM; J COLLINS; A HILB
Journal:  Arch Dis Child       Date:  1962-02       Impact factor: 3.791

3.  Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis.

Authors:  S K Dutta; V S Hubbard; M Appler
Journal:  Dig Dis Sci       Date:  1988-10       Impact factor: 3.199

4.  The treatment of pancreatic exocrine insufficiency. 3. The effects of pancreatic ductal ligation and oral pancreatic enzyme supplements on fecal lipid excretion in the dog.

Authors:  F W Pairent; J E Trapnell; J M Howard
Journal:  Ann Surg       Date:  1969-11       Impact factor: 12.969

5.  Lingual lipase in cystic fibrosis. Quantitation of enzyme activity in the upper small intestine of patients with exocrine pancreatic insufficiency.

Authors:  C K Abrams; M Hamosh; V S Hubbard; S K Dutta; P Hamosh
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

6.  Treatment of pancreatic exocrine insufficiency. II. Effects on fat absorption of pancreatic lipase and fifteen commercial pancreatic supplements as measured by I-131 tagged triolein in the dog.

Authors:  B B Giulian; H Mitsuoka; A O Mansfield; J E Trapnell; J A Seddon; J M Howard
Journal:  Ann Surg       Date:  1967-04       Impact factor: 12.969

7.  [Studies on the value of fecal tryptic and chymotryptic activity in the diagnosis and therapy of cystic fibrosis (author's transl)].

Authors:  J Weise; Y Kobayashi; W Tolckmitt
Journal:  Eur J Pediatr       Date:  1976-05-04       Impact factor: 3.183

8.  Deficiencies of essential fatty acids and vitamin E in cystic fibrosis.

Authors:  H Böhles; H Heid; K Stehr; W Fekl
Journal:  Z Ernahrungswiss       Date:  1979-07

9.  Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis.

Authors:  P R Durie; L Bell; W Linton; M L Corey; G G Forstner
Journal:  Gut       Date:  1980-09       Impact factor: 23.059

Review 10.  Characterising lipid lipolysis and its implication in lipid-based formulation development.

Authors:  Nicky Thomas; René Holm; Thomas Rades; Anette Müllertz
Journal:  AAPS J       Date:  2012-09-07       Impact factor: 4.009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.